Chi-Med Files Application to List in Hong Kong and Announces Proposed Global Offering

NEXT STORY
IVD Infectious Diseases: Worldwide Market Forecast Report to 2026 – Introduction of Technologies such as qPCR & ELISA has Enhanced Usage Rates of IVD Products for Infectious Disease Testing
PREV STORY
Santhera to Present Long-term Efficacy Results with Idebenone in DMD at the 2019 MDA Clinical and Scientific Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat Licensing rights are worldwide ...

author_avatar
NASDAQ Market News

ZIOPHARM Announces Clinical Data Highlighting Favorable Interim Survival Results with Gene Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer

– Data to be Presented at the 2016 ASCO Annual Meeting – – Company ...

author_avatar
NASDAQ Market News

Hemispherx Releases Recently Manufactured Ampligen for Pancreatic Cancer Early Access Program in the Netherlands to Fill Stock Order

ORLANDO, Fla., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) ...

author_avatar
NASDAQ Market News